2 assets in Progressive Relapsing Multiple Sclerosis

Therapeutic assets addressing Progressive Relapsing Multiple Sclerosis, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Teriflunomide Progressive Relapsing Multiple Sclerosis	Sanofi	P3	B (60)
Tolebrutinib Progressive Relapsing Multiple Sclerosis	Sanofi	P3	B (60)